Chunming Li

ORCID: 0000-0003-1187-2835
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Cardiac Imaging and Diagnostics
  • Radiopharmaceutical Chemistry and Applications
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Retinal Imaging and Analysis
  • Optical Coherence Tomography Applications
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiomyopathy and Myosin Studies
  • Medical Image Segmentation Techniques

Shanghai Jiao Tong University
2011-2025

University of Pennsylvania
2013

The registration of coronary artery structures from preoperative computed tomography angiography to intraoperative is great interest improve guidance in percutaneous interventions. However, non-rigid deformation and discrepancies both dimensions topology between the two imaging modalities present a challenge 2D/3D registration. In this study, we address problem by formulating it as centerline feature matching task propose GNN-based vessel network (GVM-Net) establish dense correspondence...

10.1109/tmi.2025.3540906 article EN IEEE Transactions on Medical Imaging 2025-01-01

The FORZA trial (FFR or OCT Guidance to Revascularize Intermediate Coronary Stenosis Using Angioplasty) prospectively compared the use of fractional flow reserve (FFR) optical coherence tomography (OCT) for treatment decisions and percutaneous coronary intervention (PCI) optimization in patients with angiographically intermediate lesions. Murray law-based quantitative-flow-ratio (μQFR) is a novel noninvasive method computation FFR. In present study, we evaluated clinical impact μQFR, FFR,...

10.1161/circinterventions.123.013191 article EN Circulation Cardiovascular Interventions 2024-04-25

e16008 Background: To explore the efficacy of combination biological target therapy and chemotherapy. Methods: Seventy-one patients (54 men 17 women aged from 30 to 83 years; mean 60) with local advanced oral-maxillofacial & head neck tumors (no indication for surgery, radiotherapy) confirmed by histology radiology, having bio-chemotherapy, were enrolled in this study. The chemotherapy regimen is CDDP 75mg/m2 d1,TAX d1, 5-Fu 750mg/ m2 d1-5 Nimotuzumab 200mg/m2/w. Results: completed 2 4...

10.1200/jco.2011.29.15_suppl.e16008 article EN Journal of Clinical Oncology 2011-05-20
Coming Soon ...